These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 15478851)

  • 1. Endoscopy-negative reflux disease: concepts and clinical practice.
    Chey WD
    Am J Med; 2004 Sep; 117 Suppl 5A():36S-43S. PubMed ID: 15478851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How to differentiate non-erosive reflux disease from functional heartburn.
    Ke MY
    J Dig Dis; 2012 Dec; 13(12):605-8. PubMed ID: 23134478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Higher prevalence of obesity in erosive gastroesophageal reflux disease].
    Biccas BN; Lemme EM; Abrahão LJ; Aguero GC; Alvariz A; Schechter RB
    Arq Gastroenterol; 2009; 46(1):15-9. PubMed ID: 19466304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastroesophageal reflux disease poorly responsive to single-dose proton pump inhibitors in patients without Barrett's esophagus: acid reflux, bile reflux, or both?
    Tack J; Koek G; Demedts I; Sifrim D; Janssens J
    Am J Gastroenterol; 2004 Jun; 99(6):981-8. PubMed ID: 15180713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
    van Pinxteren B; Sigterman KE; Bonis P; Lau J; Numans ME
    Cochrane Database Syst Rev; 2010 Nov; (11):CD002095. PubMed ID: 21069670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolving issues in the management of reflux disease?
    Yuan Y; Hunt RH
    Curr Opin Gastroenterol; 2009 Jul; 25(4):342-51. PubMed ID: 19417644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastroesophageal reflux symptoms not responding to proton pump inhibitor: GERD, NERD, NARD, esophageal hypersensitivity or dyspepsia?
    Bashashati M; Hejazi RA; Andrews CN; Storr MA
    Can J Gastroenterol Hepatol; 2014 Jun; 28(6):335-41. PubMed ID: 24719900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of early wireless esophageal pH monitoring in diagnosing functional heartburn in refractory gastroesophageal reflux disease.
    Park EY; Choi MG; Baeg M; Lim CH; Kim J; Cho Y; Park J; Lee I; Kim S; Choi K
    Dig Dis Sci; 2013 Oct; 58(10):2933-9. PubMed ID: 23765257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional heartburn and non-erosive reflux disease.
    Savarino V; Savarino E; Parodi A; Dulbecco P
    Dig Dis; 2007; 25(3):172-4. PubMed ID: 17827934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonerosive reflux disease.
    Long JD; Orlando RC
    Minerva Gastroenterol Dietol; 2007 Jun; 53(2):127-41. PubMed ID: 17557041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastroesophageal reflux disease: presentation and assessment of a common, challenging disorder.
    Soll AH; Fass R
    Clin Cornerstone; 2003; 5(4):2-14; discussion 14-7. PubMed ID: 15101491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The proton pump inhibitor test and the diagnosis of gastroesophageal reflux disease.
    Pace F; Pace M
    Expert Rev Gastroenterol Hepatol; 2010 Aug; 4(4):423-7. PubMed ID: 20678016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of distribution of intraesophageal pH during nighttime recumbency among patients with gastroesophageal reflux disease.
    Hershcovici T; Jha LK; Fass R
    J Clin Gastroenterol; 2012 Aug; 46(7):562-6. PubMed ID: 22476040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonerosive reflux disease.
    Waring JP
    Semin Gastrointest Dis; 2001 Jan; 12(1):33-7. PubMed ID: 11215854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extraesophageal symptoms: what role for the proton pump inhibitors?
    Nord HJ
    Am J Med; 2004 Sep; 117 Suppl 5A():56S-62S. PubMed ID: 15478854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiology of functional heartburn based on Rome III criteria in Japanese patients.
    Tamura Y; Funaki Y; Izawa S; Iida A; Yamaguchi Y; Adachi K; Ogasawara N; Sasaki M; Kaneko H; Kasugai K
    World J Gastroenterol; 2015 Apr; 21(16):5009-16. PubMed ID: 25945016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autofluorescence imaging endoscopy can distinguish non-erosive reflux disease from functional heartburn: A pilot study.
    Luo X; Guo XX; Wang WF; Peng LH; Yang YS; Uedo N
    World J Gastroenterol; 2016 Apr; 22(14):3845-51. PubMed ID: 27076770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Prevalence of Rome IV Nonerosive Esophageal Phenotypes in Children.
    Mahoney LB; Nurko S; Rosen R
    J Pediatr; 2017 Oct; 189():86-91. PubMed ID: 28711175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The proton pump inhibitor test for gastroesophageal reflux disease: optimal cut-off value and duration.
    de Leone A; Tonini M; Dominici P; Grossi E; Pace F;
    Dig Liver Dis; 2010 Nov; 42(11):785-90. PubMed ID: 20452300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.